BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3861603)

  • 1. New anthracycline glycosides obtained by the nitrous acid deamination of daunorubicin, doxorubicin and their configurational analogues.
    Cassinelli G; Ballabio M; Arcamone F; Casazza AM; Podesta' A
    J Antibiot (Tokyo); 1985 Jul; 38(7):856-67. PubMed ID: 3861603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New daunorubicin analogs. 3-Amino-2,3,6-trideoxy-alpha- and beta-D-arabino- and 3,6-diamino-2,3,6-trideoxy- alpha-D-ribo-hexopyranosides of daunomycinone.
    Fuchs EF; Horton D; Weckerle W; Winter B
    J Antibiot (Tokyo); 1979 Mar; 32(3):223-38. PubMed ID: 457582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone.
    Arcamone F; Penco S; Vigevani A; Redaelli S; Franchi G; DiMarco A; Casazza AM; Dasdia T; Formelli F; Necco A; Soranzo C
    J Med Chem; 1975 Jul; 18(7):703-7. PubMed ID: 168385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of antitumor-active 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Ok K; Takagi Y; Tsuchiya T; Umezawa S; Umezawa H
    Carbohydr Res; 1987 Nov; 169():69-81. PubMed ID: 3427590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antitumor activity of 7-O-[2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-alpha-L-talopyranosyl]- daunomycinone and -adriamycinone.
    Nakai K; Takagi Y; Tsuchiya T
    Carbohydr Res; 1999 Mar; 316(1-4):47-57. PubMed ID: 10420587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses and antitumor activities of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Tsuchiya T; Takagi Y; Ok K; Umezawa S; Takeuchi T; Wako N; Umezawa H
    J Antibiot (Tokyo); 1986 May; 39(5):731-3. PubMed ID: 3733524
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
    StefaƄska B; Dzieduszycka M; Bontemps-Gracz M; Borowski E; Martelli S
    J Antibiot (Tokyo); 1988 Feb; 41(2):193-8. PubMed ID: 3356607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activity of the two isomeric 2'-C-methyl daunomycins.
    Rocherolle V; Olesker A; Lukacs G
    J Antibiot (Tokyo); 1989 Sep; 42(9):1393-7. PubMed ID: 2793594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological activity of 7-O-(4-O-acetyl-3-iodo-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl) daunomycinone and 7-O-(3-chloro-2,3,6-trideoxy-4-O-propanoyl-alpha-L-lyxo- hexopyranosyl)daunomycinone.
    Aligiannis N; Pouli N; Marakos P; Mitaku S; Skaltsounis AL; Leonce S; Pierre A; Atassi G
    Chem Pharm Bull (Tokyo); 2000 Jan; 48(1):150-3. PubMed ID: 10705494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses and antitumor activities of 7-O-(3-amino-2,3,6-trideoxy-2-fluoro-alpha-L-talopyranosyl)daunomvcinone and -adriamycinone.
    Takagi Y; Park H; Tsuchiya T; Umezawa S; Takeuchi T; Komuro K; Nosaka C
    J Antibiot (Tokyo); 1989 Aug; 42(8):1315-7. PubMed ID: 2759914
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and antitumour activity of new daunorubicin and adriamycin analogues.
    Arcamone F; Bernardi L; Patelli B; Giardino P; Di Marco A; Casazza AM; Soranzo C; Pratesi G
    Experientia; 1978 Oct; 34(10):1255-7. PubMed ID: 570116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumor activity of new anthracyclines.
    Florent JC; Genot A; Monneret C
    J Antibiot (Tokyo); 1989 Dec; 42(12):1823-30. PubMed ID: 2621164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anthracycline antineoplastic drugs.
    Young RC; Ozols RF; Myers CE
    N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental evaluation of anthracycline analogs.
    Casazza AM
    Cancer Treat Rep; 1979 May; 63(5):835-44. PubMed ID: 455325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological and biochemical properties of new anthracyclines modified in the aminosugar moiety.
    Bargiotti A; Casazza AM; Cassinelli G; Di Marco A; Penco S; Pratesi G; Supino R; Zaccara A; Zunino F; Arcamone F
    Cancer Chemother Pharmacol; 1983; 10(2):84-9. PubMed ID: 6831630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. o-Methylation on anthracyclines and anthracyclinones. New o-methyl ethers of daunorubicin and its analogues.
    Cassinelli G; Di Matteo F; Forenza S; Ripamonti MC; Ruggieri D; Vigevani A; Arcamone F
    Farmaco Sci; 1982 Aug; 37(8):501-13. PubMed ID: 6957317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adriamycin analogs hydroxylated at c-3': synthesis and antitumor activity.
    Horton D; Turner WR
    Carbohydr Res; 1979 Dec; 77():C8-C11. PubMed ID: 519652
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and antitumor activity of sugar-ring hydroxyl analogues of daunorubicin.
    Fuchs EF; Horton D; Weckerle W; Winter-Mihaly E
    J Med Chem; 1979 Apr; 22(4):406-11. PubMed ID: 571021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of acute leukemia: contribution of the new anthracyclinic drugs].
    Lambertenghi-Deliliers G; Colajori E; Annaloro C; Polli EE
    Recenti Prog Med; 1985; 76(7-8):392-7. PubMed ID: 3906794
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and antitumor activity of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl) daunomycinone derivatives modified at C-3' or C-4'.
    Takagi Y; Kobayashi N; Chang MS; Lim GJ; Tsuchiya T
    Carbohydr Res; 1998 Feb; 307(3-4):217-32. PubMed ID: 9675364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.